B
arrett's esophagus (BE) is identified as a precursor lesion for the development of esophageal adenocarcinoma (EAC) and the risk of malignant transformation among patients with nondysplastic BE (NDBE) has been estimated to be between 0.12% and 0.4% per year. [1] [2] [3] In the past 40 years, there has been a rise in the incidence of EAC with few breakthroughs in medical therapies for advanced esophageal cancer.
1,4-6 As a result, more attention has been placed on surveillance endoscopy of BE with the intent of preventing EAC or diagnosing EAC at a more favorable stage. 1, 4 The results of these studies have been mixed and have prompted the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy to change their recommendations for surveillance of NDBE. In 2002, these 3 gastrointestinal (GI) societies had recommended surveillance at 1 year after diagnosis and then every 3 years; however, in 2011, their recommendations shifted to recommending surveillance endoscopy every 3-5 years. [7] [8] [9] [10] [11] To reduce overuse of testing and procedures, the American Gastroenterological Association joined the American Board of Internal Medicine in their Choosing Wisely campaign, listing that patients should question their provider if recommended to have surveillance esophagogastroduodenoscopy (EGD) sooner than 3 years after their last one. 12 However, it is not clear whether endoscopists are following the guidelines for surveillance intervals of NDBE. Prior studies have aimed to determine the use patterns of EGD among patients with NDBE and risk factors for inappropriate use. A multicenter study that involved 3 sites included 235 patients with NDBE and found that 65% of patients reported >1 endoscopy in a 3-year period, which resulted in an estimated 2.3 excess endoscopies per patient. 13 But the authors did not detect any factors that were significantly associated with overuse. 13 Another study aimed to evaluate use of endoscopy in a Veterans Affairs population; among 4499 patients with BE and 6 years of follow-up, only 6.7% had 3 or more EGDs, which they defined as probable overuser. 14 These findings seem to indicate that use of endoscopy in a Veterans Affairs population is not common and they found that Veterans Affairs patients were more likely to get endoscopically surveilled if they were white, younger than 65 years old, and had frequent outpatient visits.
14 Finally, a recent study found that patients with NDBE insured through Medicaid or without insurance were more likely to be undersurveilled as compared with those patients with private insurance. 15 It is not clear to what extent the results of these studies are generalizable to other populations. Therefore, we aimed to identify factors associated with use of endoscopy among patients with NDBE and identify trends in the appropriateness of surveillance EGD of NDBE at a large tertiary care center, the University of Michigan (UM).
Methods

University of Michigan Barrett's Esophagus Registry
The University of Michigan Barrett's Esophagus Registry (UMBER) is a retrospectively collected database of BE patients managed at UM from 1994 through 2016. Subjects were identified by querying the UM Department of Pathology database for search terms "Barrett's" and "biopsy" combined. Patients were excluded from UMBER if they did not have an EGD at UM. The electronic medical record (including imaged copies of outside hospital reports) was manually reviewed, and cases were included only if there was both endoscopic and histologic confirmation of BE. BE was defined as the endoscopic appearance or documentation of salmon-colored mucosa with corresponding findings of intestinal metaplasia with goblet cells on histologic evaluation. Data were manually abstracted using elements from the Barrett's Esophagus Translational Research Network Shared Minimal Dataset including date of endoscopies, location of endoscopies (outside hospital or UM); endoscopic findings including length of BE segment and visible esophageal lesions (nodules, esophagitis, mass, ulcers), demographic data (age, gender, race), medications, histological findings, comorbidities, and staging (pretreatment and posttreatment) if they developed EAC. In 2016, patients identified in the registry who were overdue for surveillance endoscopy were contacted via telephone and letter notifying them that they were due for surveillance. If a patient had an endoscopy at an outside institution in the intervening time-period, attempts were made to obtain their endoscopic reports after obtaining a waiver for their medical records. Study data were collected and managed using REDCap electronic data capture tools hosted at UM. 16 
Identification of Use Patterns
UMBER was used to identify patients with NDBE. Patients with a history of dysplasia (low-grade, indefinite, high-grade dysplasia) and EAC were excluded from the analysis (Figure 1 ). To allow for patients who had a repeat EGD within 1 year of their NDBE diagnosis, as per guideline recommendations before 2011, our primary outcome relied on the time between their second and third EGD. We included patients who had at least 3 EGDs or at least 5 years of follow-up since their last EGD. To account for differences in surveillance recommendations from GI societies before 2002, we excluded any patient who had their index endoscopy before 2002. Furthermore, we excluded any patient whose second EGD was done outside of the UM. Last, we excluded patients who did not have a UM primary care provider (PCP) because those patients may be more likely to have missing data on outside endoscopies.
Over-utilizers were defined as those patients who had less than 3 years between their second and third EGD. Under-utilizers were defined as those patients who had greater than 5 years between their second and third EGD or who never received their third EGD. We also classified patients who never received their second EGD as never-surveyed. All patients were compared with those who underwent appropriate surveillance, defined as between 3 and 5 years between their second and third EGD.
Variables of Interest and Primary Outcomes
The variables of interest in our study included sex; race; age at the last endoscopy; year of the second endoscopy; length of Barrett's segment (short segment or long segment, defined as <3 cm or !3 cm); income estimated by patient zip code; distance to the UM estimated by patient zip code; Charlson Comorbidity Index; a family history of esophageal cancer; and the referring physician for their first, second, and third endoscopies (UM GI provider vs PCP). Indications for repeat endoscopy among our cohort were defined as Barrett's related if the endoscopy indication was listed as suspected BE, surveillance of BE, or follow-up of BE; all other indications (n ¼ 17) were defined as non-Barrett's related indications. Mean household income for zip codes was obtained from the 2010 US Census data and distance to the UM was calculated using the length of the shortest curve between the patient's zip code and UM.
The primary outcomes of our study were the effects of patient factors, year, and referring providers on appropriateness of surveillance intervals.
Statistical Analysis
Student t test was used for continuous variables and Fisher exact test or chi-square test was used for categorical variables. Logistic regression was used to estimate the odds ratios for our variables of interest among the 4 utilization groups included in our study.
Stepwise forward regression was used to develop the multivariable model. Sensitivity analyses were conducted additionally including patients whose PCP was outside the UM system and restricted to patients with more recent second endoscopy (overuse and underuse) or first endoscopy (never-surveilled). The year 2008 was chosen because new guideline recommendations were published at that time (Supplementary material). Stata version 14 was used to perform all analyses (StataCorp, College Station, TX).
Results
A total of 3445 patients with BE were identified in the pathology database. A total of 145 patients were excluded because there were no data available in the electronic medical record. We then excluded 1692 patients with dysplasia, no BE on endoscopy, or less than 5 years of follow-up; 600 patients with an index endoscopy before 2002; 63 patients who had their second endoscopy at an outside institution; and 468 patients with no PCP at the UM. A total of 477 patients were included in our analysis ( Figure 1 ). There were 76 (15.9%) patients with appropriate surveillance, 181 (37.9%) patients who were over-surveilled, 145 (30.4%) patients who were never-surveilled, and 75 (15.7%) patients who were under-surveilled.
Overall, most of our cohort were male (65.8%), white persons (91.4%), and had a mean age of 60.9 AE 13.7 years at the time of the last endoscopy (Table 1) . A total of 74.0% of over-utilizers, 70.3% of under-utilizers, and 51.1% of never-surveilled patients had a UM GI provider refer them for their third, second, and first endoscopy, respectively. In addition, 22.4% had long-segment BE ( Table 1) . The indication for a repeat endoscopy in most patients was for Barrett's-related reasons ( Table 1) .
As per our study protocol, we contacted overusers who were due for their endoscopic surveillance. During that process, we identified a total of 43 patients (12 over- utilizers, 7 under-utilizers, and 24 never-surveilled patients) who died and did not receive their follow-up endoscopy.
Over-utilization of Endoscopy
In univariable analysis, over-utilization of surveillance endoscopy was less likely if a UM PCP referred the patient for their third endoscopy, as compared with a UM GI provider (Table 2) . Furthermore, a more recent year of second endoscopy, from 2006 to 2011, was protective of over-utilization. However, long-segment BE and a higher Charlson Comorbidity Index was associated with an increased risk of over-utilization (Table 2 ). In multivariable analysis, there were only 2 factors found to be associated with over-surveillance. Long-segment BE was associated with an almost 4 times higher risk of over-utilization as compared with short-segment BE (adjusted odds ratio [aOR], 3.78; 95% confidence interval [CI], 1.51-9.46) ( Table 2) . Furthermore, a PCP at the UM as the referring physician for the third endoscopy was associated with a reduced risk of over-surveillance as compared with a UM GI provider (aOR, 0.51; 95% CI, 0.27-0.95) ( Table 2) .
Underuse of Endoscopy
In univariable analysis, male patients, those with long-segment BE, those at the farthest distance from the UM, and patients with a higher Charlson Comorbidity Index were associated with an increased risk of underutilization (Table 3 ). There was a trend toward patients who were referred by a UM PCP for their second endoscopy being less likely to be under-surveilled (Table 3 ). In multivariable analysis, an older age at the time of the last endoscopy (aOR, 0.74 per year; 95% CI, 0.54-0.90) and a body mass index >30 kg/m 2 (aOR, 0.39; 95% CI, 0.15-0.99) were protective of being undersurveilled (Table 3) . However, male patients, those with long-segment BE, those with a higher Charlson Comorbidity Index, and patients at the farthest distance from the UM were at increased risk of under-utilizing surveillance endoscopy for NDBE (Table 3) .
Never Surveilled
In univariable analysis, male patients, those with long-segment BE, and those with a higher Charlson Comorbidity Index were associated with an increased risk of never receiving their first surveillance endoscopy (Table 4) . Patients who were referred by a UM PCP for their first endoscopy trended toward being protected from being never-surveilled (Table 4) . Patients with long segment BE and those patients with a higher Charlson Comorbidity Index were associated with an increased risk of never being surveilled (Table 4 ). In the multivariable analysis, male patients (aOR, 1.90; 95% CI, 1.01-3.57), long-segment BE (aOR, 3.02; 95% CI, 1.10-8.25), and a higher Charlson Comorbidity Index (aOR, 3.01; 95% CI, 1.19-7.58) were associated with an increased risk of never being surveilled (Table 4) .
Discussion
In this single-center cohort study, we found that there was a small minority of patients who received appropriate surveillance for their NDBE. A UM PCP as the referring provider for the third endoscopy was protective of over-utilization and this trend was also seen among patients who were under-surveilled or neversurveilled. Male patients, those with long-segment BE, and patients with a higher Charlson Comorbidity Index were at increased risk of both under-surveillance and never being surveilled. PCPs are critical in the management of patients with chronic illnesses and prior studies have found that visits to PCPs account for more than 50% of all office visits. 17, 18 The relationship between PCPs and specialists is an integral component of care for many patients. Studies have found that poor coordination and communication between PCPs and specialist physicians contribute to avoidable patient morbidity and mortality, fragmented care, and increased costs. [19] [20] [21] In addition, the PCP-specialist physician relationship has been closely evaluated among cancer patients and survivors, with the 2005 Institute of Medicine report emphasizing that coordination between specialists and PCPs remains 1 of the 4 key components to cancer survivorship care. 21, 22 Within gastroenterology, the presence of a PCP at a center has been associated with an increased likelihood of patients attending their outpatient gastroenterology clinic appointments and improved coordination of colorectal cancer screening. 23, 24 PCPs also have an expanding role in the management of patients with hepatitis C and cirrhosis. [23] [24] [25] However, to our knowledge, the role of PCPs in the management of patients with BE has not yet been explored. Our study found that the presence of a PCP at the UM decreases the risk of overuse and trended toward protecting under-surveilled and never-surveilled patients. The findings of our study suggest that PCPs play an important role in the health care use of endoscopic resources for patients with NDBE and presumably help to coordinate care between patients and their specialist physician. Another consideration is the use of patient navigation programs, which have been shown to be an effective intervention to help overcome barriers in health care systems, especially among patients who may not have a PCP or if PCP engagement is not effective. [26] [27] [28] [29] [30] [31] Furthermore, our study found that patients who were under-surveilled and never-surveilled had similar risk factors for inappropriate surveillance. Male patients were more likely to be under-surveilled or neversurveilled. Prior studies in the infectious diseases and orthopedic trauma surgery literature have found a similar independent risk for male patients to be lost to follow-up or not return for their regularly scheduled appointments. 32, 33 In addition, the distance from the UM also played an important role in being under-surveilled, specifically among those patients who were >47 miles from the university. Lastly, patients with a higher number of comorbidities per the Charlson Comorbidity Index were at higher risk of being under-surveilled or neversurveilled which may be appropriate and reflect an informed decision with their provider regarding the risk and benefits of surveillance endoscopy considering their comorbidities. Given that most BE patients are male, it is important to recognize their increased risk of inappropriate or decreased surveillance, which has also been noted in a prior study that found that patients at lowest risk of BE (women) are more likely to receive endoscopic screening for gastroesophageal reflux disease as compared with men. 34 We acknowledge that there are limitations to our study. First, given that the data are retrospective, patients could have received appropriate endoscopic surveillance at an outside hospital without our knowledge. However, our study did make attempts to contact patients who were overdue for surveillance EGD after the initial data collection to determine if they have received a surveillance EGD at an outside institution and our current data reflect their updated records. Second, this is a single-center study in which the results may not be generalizable to other centers. Third, long-segment Barrett's disease was associated with an increased risk of over-surveillance, under-surveillance, and neversurveilled in our multivariable analyses, as compared with appropriate surveillance. Perhaps over-surveillance of long-segment BE is driven by concerns of the increased risk of cancer, and under-surveillance and never surveillance are driven by relative resolution of gastroesophageal reflux symptoms compared with patients with short-segment BE. These findings need to be validated and explored further in additional studies. Fourth, we identified 43 patients who did not receive their endoscopy because of death and there could be additional deaths of which we are unaware. Last, we did exclude those patients who did not have a PCP at the UM given the concern for missing data on outside endoscopies. However, a supplementary analysis that included patients with an outside hospital PCP was similar to the findings of the primary analysis ( Supplementary  Tables 1-3 ).
Our study does have several strengths. To our knowledge, it is the first study to identify patient factors, outside of insurance status, that are associated with both over-surveillance and under-surveillance of endoscopy among patients with NDBE. Prior studies that have evaluated surveillance endoscopy among patients with NDBE were not able to identify patientrelated factors associated with use patterns. Second, to our knowledge, our study is also one of the first to explore risk factors for never being surveilled or being under-surveilled, both of which are important and vital to describe as the health care system grows and becomes more complex. Third, our study focused on patients who had their index endoscopy after 2002 and on the time interval between the second and third endoscopy only to better understand use patterns according to more recently updated guidelines. Fourth, given the number of patients with NDBE in the UMBER dataset, we were able to examine associations with a large number of factors among the different groups of patients studied.
In conclusion, our study found that appropriate surveillance intervals were uncommon (15.95%), with oversurveillance (37.9%), under-surveillance (15.7%), and never surveillance (30.4%) all occurring frequently. Furthermore, we found several factors that were associated with an increased risk of inappropriate surveillance including the importance of a PCP at the center where surveillance occurs to decrease the risk of inappropriate surveillance. Future efforts should focus on identifying barriers to receiving endoscopic surveillance among NDBE patients with particular attention to those patients who are the most vulnerable and improving the coordination of care between endoscopists and PCPs, particularly if the PCP is not in the same health care system.
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Sensitivity Analyses
We repeated the analyses additionally including patients whose primary care provider was not in the University of Michigan system, finding similar associations with over-surveillance (Supplementary Table 1 ). There was attenuation of some of the effect estimates for associations with under-surveillance (Supplementary Table 2 ) and never-surveillance (Supplementary Table 3) , and distance to University of Michigan was found to be associated with never-surveillance in the fully adjusted model (Supplementary Table 3 ).
To evaluate the effect of new guideline recommendations for Barrett's esophagus surveillance from 2008, we fitted multivariable logistic regression models restricted to those patients whose endoscopy was since 2008. We found similar effect estimates (although with greater imprecision in those estimates) for over-surveilled, under-surveilled, and never surveilled. In addition, in regression models for the entire cohort, there was no effect of year of endoscopy con the risk of being over-surveilled, under-surveilled, and never-surveilled (data not shown). 
